EP4316598 - PHARMACEUTICAL COMPOSITION CONTAINING POORLY-SOLUBLE BASIC MEDICINE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 12.07.2024 Database last updated on 24.07.2024 | |
Former | The application has been published Status updated on 05.01.2024 | Most recent event Tooltip | 12.07.2024 | The date on which the examining division becomes responsible, has been established | 12.07.2024 | Request for examination filed | published on 14.08.2024 [2024/33] | 12.07.2024 | Change - designated states | published on 14.08.2024 [2024/33] | Applicant(s) | For all designated states CHUGAI SEIYAKU KABUSHIKI KAISHA 5-1, 5-chome Ukima Kita-ku Tokyo 115-8543 / JP | [2024/06] | Inventor(s) | 01 /
KITAYAMA, Akira Tokyo, 115-8543 / JP | 02 /
SASOH, Takeshi Tokyo, 115-8543 / JP | [2024/06] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2024/06] | Application number, filing date | 23212247.3 | 28.06.2019 | [2024/06] | Priority number, date | JP20180124830 | 29.06.2018 Original published format: JP 2018124830 | [2024/06] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4316598 | Date: | 07.02.2024 | Language: | EN | [2024/06] | Type: | A3 Search report | No.: | EP4316598 | Date: | 17.04.2024 | Language: | EN | [2024/16] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.03.2024 | Classification | IPC: | A61K31/5377, A61K9/20, A61K47/02, A61K47/18, A61K47/20, A61K47/32, A61K47/38, A61P25/24, A61P25/28, A61P35/00, A61P35/04, A61P43/00 | [2024/16] | CPC: |
A61K9/2009 (EP,KR,US);
A61K31/5377 (EP,IL,KR,US);
A61K9/2013 (EP,KR,US);
A61K47/02 (IL);
A61K47/18 (IL);
A61K47/20 (IL,KR);
A61K47/32 (IL);
A61K47/38 (IL);
A61K9/20 (IL);
A61K9/2018 (US);
A61K9/2027 (KR,US);
A61K9/205 (KR);
A61K9/2054 (US);
A61K9/2059 (KR);
A61P25/24 (EP,IL,KR);
A61P25/28 (EP,IL,KR);
A61P35/00 (EP,IL,KR);
A61P35/04 (EP,IL,KR);
A61P43/00 (EP,IL)
(-)
|
Former IPC [2024/06] | A61P43/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/33] |
Former [2024/06] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT SCHWER LÖSLICHER BASISCHER MEDIZIN | [2024/07] | English: | PHARMACEUTICAL COMPOSITION CONTAINING POORLY-SOLUBLE BASIC MEDICINE | [2024/06] | French: | COMPOSITION PHARMACEUTIQUE CONTENANT UN MÉDICAMENT BASIQUE PEU SOLUBLE | [2024/07] |
Former [2024/06] | PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND EIN SCHWERLÖSLICHES BASISCHES MEDIKAMENT | ||
Former [2024/06] | COMPOSITION PHARMACEUTIQUE CONTENANT UN MÉDICAMENT BASIQUE FAIBLEMENT SOLUBLE | Examination procedure | 11.07.2024 | Examination requested [2024/33] | 11.07.2024 | Date on which the examining division has become responsible | Parent application(s) Tooltip | EP19826841.9 / EP3815688 | Fees paid | Renewal fee | 21.12.2023 | Renewal fee patent year 03 | 21.12.2023 | Renewal fee patent year 04 | 21.12.2023 | Renewal fee patent year 05 | 24.06.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2012023597 (CHUGAI PHARMACEUTICAL CO LTD [JP], et al); | [A]WO2015163448 (CHUGAI PHARMACEUTICAL CO LTD [JP]); | [A]WO2016021707 (CHUGAI PHARMACEUTICAL CO LTD [JP]); | by applicant | JP2009100783 | JP4588121B | JP4918630B | JP5006987B | WO2015163447 | JP5859712B | WO2016021707 |